PAYER POLICY CHANGES

S3846 Insurance Policy Changes

HCPCS S3846 is officially defined as "Genetic testing for hemoglobin e beta-thalassemia." HCPCS S3846 is referenced in 1 tracked payer policy change from Excellus BlueCross BlueShield. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S3846 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch S3846

Get one email when a payer policy names S3846, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for S3846

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for S3846 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.